Cambridge, MANCT05649059Now EnrollingIRB Ready

Phobia, Social Clinical Trial in Cambridge, MA

Access cutting-edge phobia, social treatment through this clinical trial at a research site in Cambridge. Study-provided care at no cost to qualified participants.

Sponsored by Massachusetts Institute of Technology

Quick Self-Assessment

See if you qualify for this Cambridge location

Preparing your pre-screening questions…

Expert Care in Cambridge

Access phobia, social specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related phobia, social treatment provided free

Apply for This Cambridge Location

Check if you qualify for this phobia, social clinical trial in Cambridge, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cambridge

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cambridge site if eligible
  4. 4Begin participation

About This Phobia, Social Study in Cambridge

The purpose of this study is to test whether a single-dose of Epidiolex (cannabidiol) is associated with reduced psychological, physiological, and neuroimaging measures of anxiety in people diagnosed with social anxiety disorder (SAD).

Sponsor: Massachusetts Institute of Technology

Who Can Participate

Inclusion Criteria

Ability and willingness to provide written informed consent.
Sufficiently fluent in English to participate in the trial.
Between 18-55 years of age (inclusive).
Right-hand dominant.
Current medications are stable for past 30 days (no changes to dose or frequency).
Negative result on pregnancy test (if female).
Negative result on urine drug screening.
Liebowitz Social Anxiety Scale (LSAS ≥ 60).

Exclusion Criteria

History of bipolar disorder, schizophrenia, psychosis, delusional disorders.
History of eating disorder within past 6 months.
History of any traumatic brain injury.
Currently diagnosed with diabetes mellitus.
Presence of severe medical illness that would prevent completion of study procedures.
Presence of significant neurological illness or cognitive dysfunction (e.g.; seizures, dementia).
History of substance use disorder within past 6 months (other than nicotine and caffeine).
Use of any cannabis-containing products in past 30 days (CBD or THC).
Use of benzodiazepines in past 2 weeks.
Use of alpha- or beta-blockers in past week.
History of claustrophobia.
Contraindications for MRI (e.g.; shrapnel).
Presence of any other medical condition that, in the investigator's opinion, may interfere with the study procedures.
Use of concomitant medication that has a strong interaction with CBD.
History of liver disease.
History of hypersensitivity to cannabinoids.
History of hypersensitivity to sesame seed oil.
Currently breastfeeding (if female).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cambridge?

Yes, this clinical trial (NCT05649059) has an active research site in Cambridge, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Phobia, Social Treatment Options in Cambridge, MA

If you're searching for phobia, social treatment options in Cambridge, MA, this clinical trial (NCT05649059) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cambridge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced phobia, social specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all phobia, social clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Hypertension Trials in Cambridge, MA

See all pulmonary hypertension clinical trials recruiting in Cambridge — not just this study.

Browse Pulmonary Hypertension Trials in Cambridge →

Browse More Trials by Condition

Pulmonary Hypertension TrialsAll Conditions →

Ready to Join in Cambridge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cambridge, MA